| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
EzetimibeLipoprotein (Dyslipoproteinemia Hyperlipoproteinemia)StatinTorcetrapibNiacinColesevelamAvasimibeFibrateImplitapideCholesterolNPC1L1 Niemann Pick C1 Like1| 1 | 2008 | Given the ENHANCE trial results, ezetimibe is still unproven. | 
| + | - | nl | Cleve Clin J Med 75(7):497-8, 502, 505-6 (2008) Taylor AJ |
| 2 | 2003 | Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor. |
| + | - | nl | Cardiovasc Drug Rev 21(4):293-312 (2003) |
| 3 | 2008 | Combination therapy in cholesterol reduction: focus on ezetimibe and statins. |
| + | - | nl | Vasc Health Risk Manag 4(2):267-78 (2008) |
| 4 | 2008 | Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation. |
| + | - | nl | Health Technol Assess 12(21):iii, xi-xiii, 1-212 (2008) |
| 5 | 2008 | Ezetimibe blocks internalization of the NPC1L1/cholesterol complex. |
| + | - | nl | Cell Metab 7(6):469-71 (2008) |
| 6 | 2008 | Ezetimibe, a selective inhibitor of the transport of cholesterol. |
| + | - | nl | Intern Med 47(13):1165-70 (2008) |
| 7 | 2005 | A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. |
| + | - | nl | Mayo Clin Proc 80(5):587-95 (2005) Pearson TA |
| 8 | 2008 | Use of ezetimibe in the United States and Canada. |
| + | - | nl | N Engl J Med 358(17):1819-28 (2008) |
| 9 | 2006 | Lipid-lowering drugs. |
| + | - | nl | Cell Mol Life Sci 63(10):1165-78 (2006) |
| 10 | 2010 | NPC1L1 and cholesterol transport. |
| + | - | nl | FEBS Lett 584(13):2740-7 (2010) |
| 11 | 2010 | Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant. |
| + | - | nl | Saudi J Kidney Dis Transpl 21(6):1021-9 (2010) |
